Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial
Kevin M. Kalinsky, Melissa Kate Accordino, Codruta C. Chiuzan, Prabhjot Singh Mundi, Elizabeth A. Sakach, Claire M. Sathe and 17 more
- Rank
- 38 of 529
- Percentile
- top 7.2%
- Where
- Journal of Clinical Oncology, 2023
- Citations
- 214
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.